Evidence Hub

Efficacy of macitentan/tadalafil single-tablet combination therapy vs pooled monotherapy in pulmonary arterial hypertension (PAH): A DUE post hoc analysis

E. Grünig, F. Fan, K. Chin, Assunta Senatore, J. Hauser, M. Friberg, H. Rofael, P. Jansa

Pulmonary hypertension, 2024

Abstract

Combination of an endothelin receptor antagonist and a phosphodiesterase 5 inhibitor is recommended in low/intermediate risk PAH. In A DUE, a single-tablet, fixed-dose combination of macitentan 10mg and tadalafil 40mg (M/T FDC) significantly improved pulmonary vascular resistance (PVR; primary endpoint) in PAH patients vs macitentan and vs tadalafil monotherapy. The safety profile of M/T FDC was in line with macitentan and tadalafil. To assess the benefit of a combination therapy strategy vs monotherapy at treatment initiation and at escalation, this post hoc analysis examined the effect of M/T FDC vs a pooled monotherapy group (receiving either macitentan or tadalafil) in patients who were either treatment-naïve or on prior monotherapy at randomisation. A DUE ( NCT03904693 ) randomised WHO functional class II/III PAH patients to M/T FDC, macitentan or tadalafil. Changes from baseline to Week 16 in PVR, 6-minute walk distance (6MWD), and N-terminal pro-brain natriuretic peptide (NT-proBNP) were analysed. Consistent with the primary analysis, in this post hoc analysis of treatment-naïve and prior monotherapy patients, single-tablet macitentan/tadalafil fixed-dose combination improved PVR, 6MWD and NT-proBNP to a greater extent than pooled monotherapy (Table), supporting the effectiveness of a combination therapy approach over monotherapy in PAH. erj;64/suppl_68/PA4306/F1 F1 F1

How strong is the evidence?

Evidence Hub reads this as a secondary / pooled analysis. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free